Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Allergan, Inc.    AGN   US0184901025

ALLERGAN, INC. (AGN)

28
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

Allergan, Inc. : Allergan Gets Subpoena From Government Over Lap-Band System

05/07/2012 | 06:11pm US/Eastern
Recommend:
0
   By Anjali Athavaley 
   Of  
 

Allergan Inc. (AGN) received a subpoena this month from the Department of Health and Human Services requesting documents related to the company's Lap-Band System for obesity, according to a filing.

Lap-Band is approved to help obese patients lose weight. It is inserted surgically through a small incision and placed at the top of the stomach. The inflatable band can be tightened or loosened to reduce or enlarge stomach capacity.

An Allergan spokeswoman declined to comment further.

Earlier this month, Allergan said its first-quarter earnings rose 45% on double-digit sales growth in its specialty-pharmaceuticals business. But sales in Allergan's obesity intervention category slipped 15.5% as high unemployment, lofty co-payments and rigid requirements from insurers pressured sales.

Last December, the U.S. Food and Drug Administration warned nine groups, mostly surgical centers in California, that if they continue misleading advertising for Lap-Band, they could face monetary penalties and have inventory seized. The FDA made no allegations against Allergan at the time.

Allergan shares were up fractionally to $93.79 in after-hours trading Monday. The stock is up nearly 7% so far this year.

-By Anjali Athavaley, Dow Jones Newswires; 212-416-4912; anjali.athavaley@dowjones.com

Recommend :
0
React to this article
Latest news on ALLERGAN, INC.
3d ago ALLERGAN : Valeant Pharmaceuticals Files An Official Complaint With The Autorite..
3d ago ALLERGAN : Earnings and Equity Performance Review -- Allergan
3d ago ALLERGAN : Announces OZURDEX® (dexamethasone 700 mcg intravitreal implant in app..
5d ago ALLERGAN : Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acqui..
5d ago ALLERGAN : Patent Application Titled "Topical Treatment for Chemotherapy Induced..
5d ago ALLERGAN : Other Events (form 8-K)
6d ago ALLERGAN : 2Q profit climbs 16 percent
6d ago ALLERGAN : Syntaxin Assigned Patent
6d ago ALLERGAN : cuts jobs, lifts profit
6d ago ALLERGAN : cuts jobs, lifts profit
Advertisement
Chart
Duration : Period :
Allergan, Inc. Technical Analysis Chart | AGN | US0184901025 | 4-Traders
Income Statement Evolution
Allergan, Inc. : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF